Manufacturing highly potent drug products is technically and financially
demanding; as a result, drug manufacturers are becoming increasingly reliant on
contract service providers
Roots Analysis is pleased to announce the publication of its recent
study, titled, “HPAPI
and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”
The report features an extensive study of the current
market landscape and future opportunities associated with the contract
manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed
analysis of the key drivers and trends related to this evolving domain. In
addition to other elements, the study includes:
§
A detailed assessment of the current market landscape of companies
offering contract services for manufacturing HPAPIs and cytotoxic drugs.
§
A competitiveness analysis of HPAPI and cytotoxic drugs
contract manufacturers, featuring insightful representations.
§
Detailed profiles of leading contract manufacturers of
HPAPI and cytotoxic drugs (shortlisted on the basis of proprietary
criterion).
§
An analysis of the partnerships that have been established
in this domain, in the recent past.
§
An analysis of the various expansion initiatives undertaken
by the players in this domain.
§
An estimate of the overall, installed capacity for
manufacturing HPAPIs and cytotoxic drugs based on data reported by industry
stakeholders in the public domain.
§
A qualitative analysis to decide whether to manufacture the
potent products in-house or engage the services of a CMO.
§
A discussion on affiliated trends, key drivers and
challenges which are likely to impact the industry’s evolution.
§
A case study on the antibody drug conjugates (ADCs) manufacturing
market, highlighting a list of contract service providers and in-house
manufacturers in this domain.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§ Type
of Product
§ HPAPIs
§ Highly
Potent Finished Dosage Forms
§
Company Size
§
Small-sized
§
Mid-sized
§
Large / Very Large
§ Scale
of Operation
§
Preclinical / Clinical
§ Commercial
§ Type
of Pharmacological Molecule
§
Small Molecules
§
Biologics
§ Type
of Highly Potent Finished Dosage Form
§ Injectables
§ Oral
Solids
§ Creams
§
Others
§ Key
geographical regions
§ North
America
§ Europe
§ Asia
Pacific
§ Rest
of the World
The report includes detailed transcripts of discussions
held with the following senior level representatives of stakeholder companies:
§
Antonella Mancuso (Vice President and Chief Operating
Officer, BSP Pharmaceuticals) and Maria Elena Guadagno (Business Director, BSP
Pharmaceuticals)
§
Klaus Hellerbrand (Managing Director, ProJect Pharmaceutics)
§
Kevin Rosenthal (Business Head, Formulations and Finished
Products, Alphora Research)
§
Jennifer L Mitcham (Director, Business Development,
Catalent Pharma Solutions) and Stacy McDonald (Group Product Manager, Catalent
Pharma Solutions)
§
Roberto Margarita (Business Development Director,
CordenPharma)
§
Allison Vavala (Senior Manager, Business Development,
Helsinn)
§
Mark Wright (Site Head, Piramal Healthcare)
§
Javier E. Aznárez Araiz (Business Development Technician,
Idifarma)
Key
companies covered in the report
§
AbbVie Contract Manufacturing
§
CARBOGEN AMCIS
§
Catalent
§
Evonik
§
Formosa Laboratories
§
Intas
§
Lonza
§
MabPlex
§
Pfizer CentreOne
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html
Other Recent Offerings
1. Antibody Contract
Manufacturing
Market, 2020 – 2030
2. Cell Therapy
Manufacturing
Market (3rd Edition), 2019 – 2030
3. Biopharma Contract
Manufacturing
Market (3rd Edition), 2019 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
